Rapid Influenza Diagnostics Market Analysis

  • Report ID: 5310
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Rapid Influenza Diagnostics Market Segmentation:

Product Type Segment Analysis

The lateral flow immunoassays subsegment in the market is expected to hold the highest market share of 43% within the forecast period in the product type segment due to its rapid, easy-to-use format and high sensitivity compared to traditional methods like the hemagglutinin (HA) test. As per a report by NLM in June 2023, technologies, such as the immunochromatographic strip, have been developed that can detect avian avulavirus 1 within 36 hours post-infection, showing the effectiveness of lateral flow assays in early and precise detection. Their adaptability and suitability for use with point-of-care testing only stimulate extensive application in clinical and field settings.

Sample Type Segment Analysis

The nasal swab subsegment in the market is expected to hold the second-highest share during the forecast period in the sample type segment due to ease of handling, minimal discomfort, and high sensitivity for the identification of influenza viruses. According to the April 2023 NLM article, nasal swab sensitivity was more than 97.7% for low and moderate Ct values. Nasal swabs are very popular in clinical and point-of-care laboratories owing to the fact that they provide the sample quickly without needing any special training. Growing use of rapid tests based on nasal swabs also supports effective screening and early detection, leading to strong demand for this segment.

End user Segment Analysis

Hospitals are expected to hold the third-highest market share in the end user subsegment during the forecast period in the market, as they are the most crucial in treating and containing influenza outbreaks, and providing full patient care. Rapid tests are required by hospitals to accelerate the detection of influenza infections, make the correct treatment choices, and prevent nosocomial spread. Additionally, hospital investments in more sophisticated diagnostic facilities and equipment encourage the utilization of rapid influenza diagnostics, further solidifying their role as the strongest end-user market segment.

Our in-depth analysis of the global market includes the following segments: 

Segment

Subsegments

Product Type

  • Lateral Flow Immunoassays
  • Molecular Diagnostics
  • Immunofluorescence Assays
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Others

Technology

  • Molecular Diagnostics
  • Immunoassays
  • Biosensors
  • Microfluidic Devices
  • Others

End user

  • Hospitals
  • Diagnostic Laboratories
    • Molecular Diagnostics
    • Immunoassays
    • Biosensors
    • Microfluidic Devices
  •  
  • Clinics
  • Home Care Settings
  • Others

Distribution Channel

  • Hospital Pharmacies
    • Nasal Swab
    • Throat Swab
    • Nasopharyngeal Swab
    • Blood
    • Saliva
  • Retail Pharmacies
  • Online Pharmacies
  • Direct Sales
  • Others

Sample Type

  • Nasal Swab
  • Throat Swab
  • Nasopharyngeal Swab
  • Blood
  • Saliva

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the rapid influenza diagnostics market was valued at USD 1.5 billion.

The market size for the rapid influenza diagnostics market is projected to reach USD 2.9 billion by the end of 2035, expanding at a CAGR of approximately 8.7% during the forecast period, i.e., between 2026–2035.

The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Quidel Corporation, Thermo Fisher Scientific Inc., and others.

In terms of technology, the lateral flow immunoassays subsegment is anticipated to garner the largest market share of 43% by 2035 and exhibit substantial growth opportunities during 2026–2035.

The market in North America is projected to hold the largest market share of 37% by the end of 2035 and offer substantial business opportunities in the coming years.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos